साई व्हाइब्रियोनिक्स पत्रिका

When this 63-year-old female, otherwise healthy with normal vision, arrived in the UK from India in the third week of June 2018, suddenly she could not move her left eye ball; she felt it had frozen in one position and her vision was impaired. Worried, she immediately consulted a doctor on 25 June 2018. She was referred to an ophthalmologist who diagnosed her condition as Miller Fisher syndrome. This is a rare autoimmune nerve condition that paralyses eye muscles and tendon reflexes, sometimes with respiratory failure. It is often preceded by viral illness which she did not have. Her husband is a vibrionics practitioner in India, so she generally avoids taking allopathic medicines. After suffering for about a week, she was able to contact a local practitioner on 2 July 2018. By that time the condition of her eyes had become worse.

She was given the following remedy:
CC7.2 Partial Vision + CC7.4 Eye defects + CC10.1 Emergencies + CC12.4 Autoimmune diseases + CC15.1 Mental & Emotional tonic + CC18.5 Neuralgia + CC19.3 Chest infections chronic + CC20.4 Muscles & Supportive tissue…QDS

CC19.3 Chest infections chronic was included to minimize the potential risk of any chest infection. 

After one week, there was 50% improvement in the movement of her affected eye and vision. After another week on 17 July, the patient reported that she could see and move her eyes normally. After ensuring that her symptoms had indeed disappeared, on 23 July, the dosage was reduced to TDS and then gradually tapered down and stopped on 13 August 2018. As of December 2019, the patient has confirmed there has been no recurrence and her eyes are functioning normally.  

Editor’s Note: The prognosis for most individuals with Miller-Fisher syndrome is good. In most cases, recovery begins within 2 to 4 weeks of the onset of symptoms, and may be almost complete within 6 months.